Proteomics-based identification of α1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas

Clinica Chimica Acta

Volumn 404, Issue 2, 2009, Pages 111-118

  Hamrita, Bechr ^a   Chahed, Karim ^a,b   Trimeche, Mounir ^c   Guillier, Christelle Lemaitre ^d   Hammann, Philippe ^d   Chaïeb, Anouar ^c   Korbi, Sadok ^c   Chouchane, Lotfi ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c FARHAT HACHED HOSPITAL   (Tunisia)

^d CNRS   (France)

Author keywords

Infiltrating ductal breast carcinomas; Serological proteome analysis; Tumor marker

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANAZOLENE SODIUM; HAPTOGLOBIN; ISOPROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; INTRADUCTAL CARCINOMA; LYMPH NODE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TISSUE FIXATION; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN; AMINO ACID SEQUENCE; BREAST NEOPLASMS; CARCINOMA, DUCTAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HAPTOGLOBINS; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 67349192924     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.03.033     Document Type: Article

References (41)

1. Jemal A., Thomas A., Murray T., et al. Cancer statistics. CA Cancer J Clin 52 (2002) 23-47
2. Brenner D.J., Sawant S.G., Hande M.P., et al. Routine screening mammography: how important is the radiation-risk side of the benefit-risk equation?. Int J Radiat Biol 78 (2002) 1065-1067
3. Duffy M.J. Serum tumor markers in breast cancer: are they of clinical value?. Clin Chem 52 (2006) 345-351
4. Hsu P.I., Chen C.H., Hsieh C.S., et al. Alpha1-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer. Clin Cancer Res 13 (2007) 876-883
5. Ahmed N., Barker G., Oliva K.T., et al. Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br J Cancer 91 (2004) 129-140
6. Rui Z., Jian-Guo J., Yuan-Peng T., et al. Use of serological proteomic methods to find biomarkers associated with breast cancer. Proteomics 3 (2003) 433-439
7. Ahmed N., Barker G., Oliva K., et al. An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum. Proteomics 3 (2003) 1980-1987
8. Chahed K., Kabbage M., Ehret-Sabatier L., et al. Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses. Int J Oncol 27 (2005) 1425-1431
9. Brunetti N.D., Padalino R., De Gennaro L., et al. Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment. J Thromb Thrombolysis (2008) 10-1007/S11239-008-0248-4 [Electronic publication ahead of print]
10. Raugei G., Bensi G., Colantuoni V., et al. Sequence of human haptoglobin cDNA: evidence that the alpha and beta subunits are coded by the same mRNA. Nucleic Acids Res 11 (1983) 5811-5819
11. Vander Straten A., Herzog A., Jacobs P., et al. Molecular cloning of human haptoglobin cDNA: evidence for a single mRNA coding for alpha 2 and beta chains. EMBO J 2 (1983) 1003-1007
12. Langlois M.R., and Delanghe J.R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42 (1996) 1589-1600
13. Tsamantanis C., Delinassios J.G., Kottaridis S., et al. Haptoglobin types in breast carcinoma. Hum Hered 30 (1980) 44-45
14. Awadallah S.M., and Atoum M.F. Haptoglobin polymorphism in breast cancer patients form Jordan. Clin Chim Acta 341 (2004) 17-21
15. Hudson B.L., Sunderland E., Cartwright R.A., et al. Haptoglobin phenotypes in two series of breast cancer patients. Hum Hered 32 (1982) 219-221
16. Gast M.C., van Tinteren H., Bontenbal M., et al. Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients. BMC Cancer 8 (2008) 389
17. Zhao C., Annamalai L., Guo C., et al. Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer. Neoplasia 9 (2007) 1-7
18. Ye B., Cramer D.W., Skates S.J., et al. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res 9 (2003) 2904-2911
19. Chen C.B., Su Y.C., Huang T.T., et al. Differentially expressed serum haptoglobin alpha chain isoforms with potential application for diagnosis of head and neck cancer. Clin Chim Acta 398 (2008) 48-52
20. Liu W., Liu B., Xin L., et al. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis. Clin Chim Acta 377 (2007) 119-126
21. Wilson N.L., Schulz B.L., Karlsson N.G., et al. Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins. J Proteome Res 1 (2002) 521-529
22. Thompson S., and Turner G.A. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera. Br J Cancer 56 (1987) 605-610
23. Oh S.K., Kim S.H., and Walker J.E. Interference with immune response at the level of generating effector cells by tumor-associated haptoglobin. J Natl Cancer Inst 82 (1990) 934-940
24. Saeed S.A., Ahmad N., and Ahmed S. Dual inhibition of cyclooxygenase and lipoxygenase by human haptoglobin: its polymorphism and relation to hemoglobin binding. Biochem Biophys Res Commun 353 (2007) 915-920
25. Westermarck J., and Kähäri V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13 (1999) 781-792
26. Snellman O., and Sylvén B. Haptoglobin acting as a natural inhibitor of cathepsin B activity. Nature 216 (1967) 1033
27. Huang X. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat Res 533 (2003) 153-171
28. Wewers M.D., Casolaro M.A., and Crystal R.G. Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy. Am Rev Respir Dis 135 (1987) 539-543
29. Yang P., Wentzlaff K.A., Katzmann J.A., et al. Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev 8 (1999) 461-465
30. Ikari Y., Mulvihill E., and Schwartz S.M. Alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and alpha 2-macroglobulin are the antiapoptotic factors of vascular smooth muscle cells. J Biol Chem 276 (2001) 11798-11803
31. Hwa J.S., Park H.J., Jung J.H., et al. Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis. J Korean Med Sci 20 (2005) 450-455
32. Léger D., Campion B., Decottignies J.P., et al. Physiological significance of the marked increased branching of the glycans of human serotransferrin during pregnancy. Biochem J 257 (1989) 231-238
33. Tamir S., Kadner S.S., Katz J., et al. Regulation of antitrypsin and antichymotrypsin synthesis by MCF-7 breast cancer cell sublines. Endocrinology 127 (1990) 1319-1328
34. Tahara E., Ito H., Taniyama K., et al. Alpha1-antitrypsin, alpha1-antichymotrypsin, and alpha2-macroglobulin in human gastric-carcinomas: a retrospective immunohistochemical study. Human Pathol 15 (1984) 957-964
35. Hurlimann J., and van Melle G. Prognostic value of serum proteins synthesized by breast carcinoma cells. Am J Clin Pathol 95 (1991) 835-843
36. Bosković G., and Twining S.S. Local control of alpha1-proteinase inhibitor levels: regulation of alpha1-proteinase inhibitor in the human cornea by growth factors and cytokines. Biochim Biophys Acta 1403 (1998) 37-46
37. Kataoka H., Uchino H., Iwamura T., et al. Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. Am J Pathol 154 (1999) 457-468
38. Scuderi P., Dorr R.T., Liddil J.D., et al. Alpha-globulins suppress human leukocyte tumor necrosis factor secretion. Eur J Immunol 19 (1989) 939-942
39. Mbeunkui F., Metge B.J., Shevde L.A., et al. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer. J Proteome Res 6 (2007) 2993-3002
40. Yavelow J., Tuccillo A., Kadner S.S., et al. Alpha 1-antitrypsin blocks the release of transforming growth factor-alpha from MCF-7 human breast cancer cells. J Clin Endocrinol Metab 82 (1997) 745-752
41. Finlay T.H., Tamir S., Kadner S.S., et al. Alpha 1-Antitrypsin- and anchorage-independent growth of MCF-7 breast cancer cells. Endocrinology 133 (1993) 996-1002